Consequently, Gal-3 plasma levels have been shown to predict a decrease in estimated glomerular filtration rate (eGFR) in various settings, including patients with CKD [8], diabetes [9], and the general population [10,11], among others. This evidence concerns the gene LGALS3 and diabetes mellitus.